搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
Medindia
1 天
Cipla Gets Green Light from CDSCO for Inhaled Insulin
Cipla secures CDSCO approval for Afrezza, its inhaled insulin, marking a breakthrough in diabetes management with innovative ...
6 天
Sol-Millennium® Celebrates Positive Feedback on Needle-Free Insulin Injection Device in Canada
Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection ...
University Press
7 天
Living with an insulin pump: How students manage diabetes while in college
At just 21 years old, recent Florida Atlantic University graduate Dylan Backer was rushed into the emergency room with a ...
Opinion
7 天
Opinion
Slaying of UnitedHealthcare executive is the wrong path for a nation with a broken medical ...
Social media celebrated the assassination of UnitedHealthcare CEO Brian Thompson. That's understandable, but wrong.
12 天
Diabetes company to lay off more than 100 employees in Andover
Embecta Corp. has notified the state that it intends to terminate 118 employees that work out of its facility at 200 Bulfinch ...
12 天
New Initiatives Expected To Make Embecta More Profitable
Embecta Corp.'s Q4 results showed significant net income and EPS growth. Embecta also announced a restructuring plan. See why ...
WAFB
14 天
A needleless alternative to Epi-pen is now available for the first time in 100 years
Maybe one of the most important differences is the lack of needles. Out of all the prescriptions that were written out for injector pens, only half of them were actually filled, according to 2023 ...
19 天
on MSN
Embecta Corp. (NASDAQ:EMBC) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript November 26, 2024 Embecta Corp. misses on earnings expectations. Reported EPS is $ EPS, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈